Genprex, Inc. (GNPX): Price and Financial Metrics

Genprex, Inc. (GNPX): $1.10

0.19 (-14.40%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add GNPX to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#216 of 332

in industry

GNPX Price/Volume Stats

Current price $1.10 52-week high $14.40
Prev. close $1.29 52-week low $0.28
Day low $1.10 Volume 977,300
Day high $1.37 Avg. volume 2,769,589
50-day MA $1.08 Dividend yield N/A
200-day MA $2.11 Market Cap 2.85M

GNPX Stock Price Chart Interactive Chart >


Genprex, Inc. (GNPX) Company Bio


Genprex, Inc., a clinical stage gene therapy company, develops drugs to treat cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). It also conducts preclinical research for developing Oncoprex to be administered with immunotherapies in NSCLC; and research into other tumor suppressor genes associated with chromosome. The company was founded in 2009 and is based in Austin, Texas.


GNPX Latest News Stream


Event/Time News Detail
Loading, please wait...

GNPX Latest Social Stream


Loading social stream, please wait...

View Full GNPX Social Stream

GNPX Price Returns

1-mo -69.36%
3-mo 54.10%
6-mo -50.00%
1-year -89.35%
3-year -98.18%
5-year -90.83%
YTD -88.04%
2023 -84.14%
2022 10.69%
2021 -68.43%
2020 1,196.88%
2019 -70.91%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!